(Q43812949)

English

Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer

scientific article published in October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

author name string

A C Matzdorff

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

G Kühnel

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

B Kemkes-Matthes

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

R Voss

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

1 reference

based on heuristic

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

129-139

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.1023/a:1012967320220

0 references

Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring platelet inhibition during chronic oral platelet glycoprotein IIb/IIIa blockade: are we missing something?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of Markers of Platelet Activation and the Interpatient Variation in Response to Abciximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of thrombosis in coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid platelet-function assay: an automated and quantitative cartridge-based method

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and total platelet glycoprotein IIb/IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ARIC hemostasis study--III. Quality control. Atherosclerosis Risk in Communities.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between inhibition of platelet aggregation and clinical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11729364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1012967320220

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43812949&oldid=2103566053"